Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition

Figure 1:  Eye Disease Prevalence, US
Table 1:  Wet AMD Therapeutics
Table 2:  Injectable Steroids for Macular Edema
Table 3:  Topical Glaucoma Products
Table 4:  Ocular Anti-inflammatory Products
Table 5: Prescription Dry Eye Treatments
Figure 2:  US Ophthalmic Market by Product Type, 2019
Table 6:  Top-Selling Prescription Ophthalmic Products, 2019
Figure 3:  Ophthalmic Revenues of Key Players, 2019
Figure 4:  Key Players with Ocular DDS Products
Table 7:  Comparison of Non-Invasive Ocular DDS
Figure 5: Durysta® Injector and Implant
Table 8:  Comparison of Invasive Ocular DDS
Table 9: Approved Ophthalmic DDS Products, US
Figure 6:  Timeline for Approved SR Ocular Implants in the US
Table 10:  Topical Glaucoma DDS Pipeline
Table 11: Sustained Release Glaucoma Pipeline
Figure 7: Clearside Bio SCS Microinjector
Table 12: Uveitis and Macular Edema DDS Pipeline
Table 13:  Ocular Pain and Inflammation DDS Pipeline
Table 14: Macular Degeneration DDS Pipeline
Table 15: Dry Eye DDS Pipeline
Table 16: Novel Therapies Pipeline
Table 17:  Examples of Ophthalmic Candidates for Long-Acting Delivery
Figure 8: Medspray Spray Nozzle Unit
Figure 9: CIS Pharma Connected Dispenser
Figure 10: Eyenovia Microdose Dispenser
Table 18:  Eyenovia Pipeline
Table 19: Optejet vs Standard Eye Dropper
Figure 11: Depiction of AcuStream Patient Administration
Table 20: Kedalion Pipeline
Figure 12: e-Novelia Smart Add-On
Figure 13: AquilaMD Ophthalmic Device
Figure 14: AesculaGel and Applicator
Figure 15: TODDD matrix
Figure 16: TODDD drug depots
Table 21: Amorphex Pipeline
Table 22: TODDD Competitive Comparison
Figure 17: Eximore punctal plug
Table 23: Eximore Pipeline
Figure 18: Inserting the Evolute plug
Table 24: Mati Therapeutics Pipeline
Figure 19: Punctum Plug Depot
Table 25: Ocular Therapeutix Pipeline
Figure 20: Visulex-P Applicator
Figure 21: Visulex-I Platform and General Visulex Process
Figure 22: Aciont MRI study
Table 26:  Aciont Pipeline
Figure 23: MiDROPS illustration
Figure 24: CMHA-S composition
Table 27: EyeGate Pipeline
Table 28: iView Pipeline
Figure 25: Proprietary Attributes of AMMPLIFY Technology
Table 29:  Kala Pipeline
Figure 26: MET Design and Process
Table 30: Novaliq Pipeline
Table 31: Santen Ophthalmic DDS Pipeline
Table 32: Sun Ophthalmic DDS Products
Table 33:  Surface Pharmaceuticals Pipeline
Figure 27: SmartCelle Delivery Schematic
Table 34:  TALLC Pipeline
Figure 28: Diagram of Common Ocular Drug Delivery Systems
Figure 29: Visual of the Episcleral System
Table 35: 3T Product Pipeline
Figure 30: Photographs of the Sustained Release Bimatoprost SR Implant
Figure 31: PRINT technology
Table 36:  Aerie Pipeline
Figure 32: SCS Microinjector
Table 37: Clearside Biomedical Pipeline
Figure 33: MDS Shown with Various 1 mL Long Prefillable Syringes
Figure 34: Durasert Implant
Table 38: EyePoint Pipeline
Table 39: Eyevensys Pipeline
Figure 35: Two Generations of iDose Implants
Table 40: Glaukos Pipeline
Figure 36: Graybug Microparticle Depot
Table 41:  Graybug Pipeline
Figure 37: iVeena Bioerodible Implant
Figure 38: Kodiak ABC Platform
Figure 39: Molecular Properties of KSI-301
Table 42: Kodiak ABC Pipeline
Figure 40: LayerForm Assembly
Figure 41: PolyNet Illustration
Table 43: LayerBio Pipeline
Figure 42: ECT Platform Schematic
Table 44:  Neurotech Pipeline
Figure 43: Classes of Therapeutics Supported by ECT Technology
Figure 44: SteriCap Mini Needle
Table 45:  PolyActiva Ophthalmic Pipeline
Figure 45: EyeLief Mechanism of Drug Release
Table 46: Benefits of Re-Vana Delivery Systems
Figure 46: The PDS Implant in Position
Figure 47: Injection Demonstration for TLC399
Figure 48: Schematic of Leo Lens MediPrint Process
Table 47:  Leo Lens Pipeline
Table 48:  Leo Lens Technology Advantages
Figure 49: OcuMedic Novel Lens Technology
Table 49:  OcuMedic Pipeline